Sharma, S., Chaturvedi, A., Dave, N. and Shah, A. 2022. Long-term efficacy and safety of RazumabTM (biosimilar ranibizumab) in Indian patients with retinal diseases: results from retrospective REAR RD-2 study. International Journal of Clinical Trials. 9, 4 (Oct. 2022), 255–262. DOI:https://doi.org/10.18203/2349-3259.ijct20222610.